Ondansetron
RxNorm 26225
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 26225 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ondansetron.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Ondansetron
(Atom ID: 12251681)
PTPrescribable
Designated preferred name (PT):
Ondansetron
(Atom ID: 420796)
FNPrescribable
Full form of descriptor (FN):
Ondansetron (substance)
(Atom ID: 420808)
PTPrescribable
Designated preferred name (PT):
Ondansetron-containing product
(Atom ID: 10808320)
FNPrescribable
Full form of descriptor (FN):
Product containing ondansetron (medicinal product)
(Atom ID: 9260673)
Patient Education
Ondansetron
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
[Learn More]
Ondansetron Injection
Ondansetron injection is used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
[Learn More]
* Please review the disclaimer below.